Search

everythinglearnresearchcommunity

for

Search:↓

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Various skin conditions like cutaneous lupus erythematosus, psoriasis, and basal cell carcinoma can be effectively treated with antihypertensive agents, NB-UVB phototherapy, and imiquimod cream respectively. Vaccines are effective against genital herpes and HPV-16 infection. Early intervention is crucial for conditions like diabetic foot ulcers and neonatal herpes. Certain dyes can cause hand dermatitis, and there's a link between smoking/drinking and psoriasis in men. No direct link was found between low iron levels and chronic hair loss in women.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.